Companies with novel uses for menstrual blood samples (a biopsy that 25% of the world’s population give every month) and those looking for new ways to treat dysmenorrhea that affects up to 90% of menstruating women.

While we have seen a number of companies addressing menstrual health, reproductive health and pregnancy there is still a noticeable lack of companies in menopause, sexual health and other forms of urogenital health.